- Home
- VERO vs PRPH Comparison
VERO vs PRPH Comparison
Compare VERO & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VERO | PRPH |
|---|---|---|
| Founded | N/A | 1989 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 4.1M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | VERO | PRPH |
|---|---|---|
| Price | $1.74 | $0.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 2.7M |
| Earning Date | 11-13-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $58,876,000.00 | $5,055,000.00 |
| Revenue This Year | N/A | $221.82 |
| Revenue Next Year | $10.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.63 | $0.50 |
| 52 Week High | $14.50 | $9.35 |
Technical Indicators
Market Signals| Indicator | VERO | PRPH |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | 59.62 |
| Support Level | $1.63 | $0.08 |
| Resistance Level | $2.08 | $1.15 |
| Average True Range (ATR) | 0.22 | 0.07 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 8.13 | 41.01 |
Price Performance
Historical ComparisonAbout VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.